Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dolichyldiphosphatase 1 is an enzyme located in the endoplasmic reticulum that hydrolyzes dolichyl pyrophosphate (Dol-P-P) to dolichyl phosphate (Dol-P), furnishing a key step for the recycling and maintenance of dolichol lipids required for proper N-glycosylation in eukaryotic cells. This enzymatic activity is necessary to maintain optimal levels of dolichol-linked oligosaccharides, thus enabling efficient glycoprotein biosynthesis. Mutations in DOLPP1 are implicated in congenital disorders of glycosylation, underscoring its essential role in protein processing and cell function.
Not applicable; the enzyme is mainly a biosynthetic regulator of dolichol metabolism and N-glycosylation, with no established drug inhibitors/modulators
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dolichyldiphosphatase 1 (DOLPP1).